SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-065359
Filing Date
2017-11-02
Accepted
2017-11-02 06:45:41
Documents
3
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-24987_18k.htm 8-K 21676
2 EX-99.01 a17-24987_1ex99d01.htm EX-99.01 149022
3 GRAPHIC g249871mmi001.jpg GRAPHIC 3042
  Complete submission text file 0001104659-17-065359.txt   176144
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 171170639
SIC: 2834 Pharmaceutical Preparations